Welahead By Welmate Lidocaine 5% Roll-on Solution
RxNorm Crosswalk NDC 83833-101

RxNorm Mapping Clinical Concepts

The product Welahead By Welmate Lidocaine 5% Roll-on (NDC 83833-101) is cross-mapped to the RxNorm terminology system to ensure clinical interoperability. This formulation is linked to a unique clinical concept (RxCUI 2670601). By anchoring Otc Pharm Llc's product data to these standardized identifiers, healthcare systems can maintain accurate medication records, safely automate e-prescribing, and streamline pharmacy workflows.

The following clinical concept cards detail the semantic term types (TTY), prescribable names, and synonymous clinical strings as defined by the National Library of Medicine (NLM).

Understanding RxNorm Mapping for Welahead By Welmate Lidocaine 5% Roll-on

RxNorm is a normalized naming system developed by the National Library of Medicine (NLM) to bridge the gap between different drug terminologies. By mapping NDC 83833-101 to RxCUI 2670601, this page provides the standardized "source of truth" required for hospital systems, e-prescribing software, and pharmacy benefit managers (PBMs) to communicate without errors.

Term Type (TTY) Legend for This Page

The clinical cards above utilize specific Term Types (TTY) to define the granularity of the drug concept:

• PSN Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
• SCD Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
• SY Synonym: An alternative clinical name or alias provided for search and retrieval clarity.

* Please review the full disclaimer at the bottom of this page.